Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Mylan and PAR – Marketwatch

July 17, 2012 Posted By: Leave a comment
SAN DIEGO, Jul 17, 2012 (GlobeNewswire via COMTEX) -- Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) , a specialty pharmaceutical company, today announced that it has entered into separate settlement arrangements with Mylan Inc. and its subsidiary ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>